Motylewska, E.; Braun, M.; Kazimierczuk, Z.; Ławnicka, H.; Stępień, H.
IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms. Pharmaceuticals 2020, 13, 354.
https://doi.org/10.3390/ph13110354
AMA Style
Motylewska E, Braun M, Kazimierczuk Z, Ławnicka H, Stępień H.
IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms. Pharmaceuticals. 2020; 13(11):354.
https://doi.org/10.3390/ph13110354
Chicago/Turabian Style
Motylewska, Ewelina, Marcin Braun, Zygmunt Kazimierczuk, Hanna Ławnicka, and Henryk Stępień.
2020. "IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms" Pharmaceuticals 13, no. 11: 354.
https://doi.org/10.3390/ph13110354
APA Style
Motylewska, E., Braun, M., Kazimierczuk, Z., Ławnicka, H., & Stępień, H.
(2020). IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms. Pharmaceuticals, 13(11), 354.
https://doi.org/10.3390/ph13110354